Regulatory T cells (Treg) can accumulate at the tumor site and block CD8+ T-lymphocytes and NK cells [Figure 5C] in their anti-tumor action as well as inhibit influx of the cells into the tumor[65,66]. The gene discussed is CD8A; the disease is neoplasm.